Bio-Rad Laboratories, Inc.Class A (BIO)
Underlying price
$369.95+1.77% today
Stock stats
- Market cap
- $9.71B
- Previous close
- $363.50
- Open
- $356.98
- Day's range
- $352.46 – $371.31
- 52-week range
- $236.73 – $396.23
- Volume
- 167K
- Avg volume
- 267K
- P/E ratio
- 43.34
- EPS
- $8.32
- Dividend yield
- -
- Beta
- 1.05
- Next earnings
- Nov 4, 2026
About Bio-Rad Laboratories, Inc.Class A
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
- Ticker
- BIO
- Asset class
- Equity
- Tokenized by
- 0 issuers
- Sector
- Technology
- Industry
- Laboratory Analytical Instruments
- Employees
- 7,450
- Website
- bio-rad.com